Insider Stock Trading History of Hoffman Stephen J


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Hoffman Stephen J since year 2005. The trader's CIK number is 1190418. At the time of this reporting, Hoffman Stephen J is the Director of Genocea Biosciences, Inc. . (stock ticker symbol GNCA). See this page for all insider trading activities at Genocea Biosciences, Inc. .

Note that in the past HOFFMAN STEPHEN J also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Hoffman Stephen J since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-03-17 GNCA Genocea Biosciences, Inc. Buy 700,000 8.25 5,775,000
2014-02-10 GNCA Genocea Biosciences, Inc. Buy 250,931 12.00 3,011,172
2014-02-04 DRNA Dicerna Pharmaceuticals Inc Buy 200,000 15.00 3,000,000
2010-01-07 ALTH Allos Therapeutics Inc Option Ex 45,429 2.42 109,892
2010-01-08 ALTH Allos Therapeutics Inc Option Ex 45,429 2.42 109,892
2010-01-07 ALTH Allos Therapeutics Inc Sale 45,429 6.76 307,100
2010-01-08 ALTH Allos Therapeutics Inc Sale 45,429 7.11 322,909
2010-01-11 ALTH Allos Therapeutics Inc Option Ex 45,428 2.42 109,890
2010-01-11 ALTH Allos Therapeutics Inc Sale 45,428 7.30 331,760
2010-01-04 ALTH Allos Therapeutics Inc Option Ex 25,428 2.42 61,510
2010-01-05 ALTH Allos Therapeutics Inc Option Ex 45,428 2.42 109,890
2010-01-04 ALTH Allos Therapeutics Inc Sale 25,428 6.54 166,222
2010-01-06 ALTH Allos Therapeutics Inc Option Ex 45,429 2.42 109,892
2010-01-05 ALTH Allos Therapeutics Inc Sale 45,428 6.64 301,505
2010-01-06 ALTH Allos Therapeutics Inc Sale 45,429 6.78 308,144
2009-02-04 ALTH Allos Therapeutics Inc Sale 36,400 9.03 328,692
2009-02-04 ALTH Allos Therapeutics Inc Option Ex 36,400 2.42 88,051
2008-09-02 ALTH Allos Therapeutics Inc Sale 40,000 9.68 387,200
2008-09-02 ALTH Allos Therapeutics Inc Option Ex 40,000 2.42 96,760

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hoffman Stephen J (Director of Genocea Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.